Granules India Ltd.

NSE: GRANULES | BSE: 532482 | ISIN: INE101D01020 | Industry: Pharmaceuticals
| Mid-range Performer

512.85
-1.08%
Emkay
Amneal and Impax announced a business merger with Amneal to be a dominant partner in the merged entity. Deal to create the 5th largest generic pharma company in the US. It appears that Impax has been valued at trailing EV/Sales of c.2.5x, which is a significant...
Granules India Ltd. average weekly volume is high.
More from Granules India Ltd.
Recommended